Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small-cell lung cancer

By Oka M.   Fukuda M.   Kuba M.   Ichiki M.   Rikimaru T.   Soda H.   Tsurutani J.   Nakamura Y.   Kawabata S.   Nakatomi K.   Narasaki F.   Nagashima S.   Takatani H.   Fukuda M.   Kinoshita A.   Kohno S.  

European Journal of Cancer, Vol. 38, Iss. 15, 2002-10 ,pp. : 1998-2004

Elsevier

Access to resources Recommend Favorite

Time Factor in Radiotherapy and Chemotherapy for Limited Disease Small-Cell Lung Cancer

By Nowara Elzbieta   Suwinski Rafal  

Cancer Investigation, Vol. 25, Iss. 3, 2007-04 ,pp. : 163-171

Informa Healthcare

Access to resources Recommend Favorite

Simultaneous integrated dose reduction intensity-modulated radiotherapy applied to an elective nodal area of limited-stage small-cell lung cancer

By            

Experimental and Therapeutic Medicine, Vol. 10, Iss. 6, 2015-01 ,pp. : 2083-2087

Spandidos Publications

Access to resources Recommend Favorite

Rapidly Alternating Combination of Cisplatin-based Chemotherapy and Hyperfractionated Accelerated Radiotherapy in Split Course for Stage IIIA and Stage IIIB Non-small Cell Lung Cancer: Results of a Phase I-II Study by the GOTHA Group

By Alberto P.   Mirimanoff R.O.   Mermillod B.   Leyvraz S.   Nagy-Mignotte H.   Bolla M.   Wellmann D.   Moro D.   Brambilla E.  

European Journal of Cancer, Vol. 31, Iss. 3, 1995-01 ,pp. : 342-348

Elsevier

Access to resources Recommend Favorite

Early Alternating Chemotherapy and Radiotherapy Schedule in Limited Disease Stage Small Cell Lung Cancer

By Purohit A.   Charloux A.   Jung G.-M.   Dietemann A.   Fraisse P.   Schumacher C.   Quoix E.  

European Journal of Cancer, Vol. 31, Iss. 9, 1995-09 ,pp. : 1434-1436

Elsevier

Access to resources Recommend Favorite